Ellie H Jhun1, Yingwei Yao2,3, Ying He1, A Kyle Mack4, Diana J Wilkie2,3, Robert E Molokie1, Zaijie Jim Wang1. 1. Department of Biopharmaceutical Sciences, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA. 2. Department of Biobehavioral Nursing Science, University of Florida College of Nursing, Gainsville, FL, USA. 3. Department of Biobehavioral Health Science, University of Illinois at Chicago College of Nursing, Chicago, IL, USA. 4. Northwestern University-Feinberg School of Medicine, Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Children's Memorial Hospital, Chicago, IL, USA.
Abstract
BACKGROUND: Prospective pain genetics research is hindered by a lack of data on the prevalence of polymorphisms in pain-relevant genes for patients with sickle cell disease (SCD). For African-Americans in general, limited information is available in public databases. METHODS: We prioritized and examined the genotype and allele frequencies of 115 SNPs from 49 candidate pain genes in 199 adult African-Americans and pediatric patients of African origin with SCD. Analyses were performed and compared with available data from public databases. RESULTS: Genotype and allele frequencies of a number of SNPs were found to be different between our cohort and those from the databases and between adult and pediatric subjects. CONCLUSION: As pain therapy is inadequate in a significant percentage of patients with SCD, candidate pain genetic studies may aid in designing precision pain medicine. We provide prevalence data as a reference for prospective genetic studies in this population.
BACKGROUND: Prospective pain genetics research is hindered by a lack of data on the prevalence of polymorphisms in pain-relevant genes for patients with sickle cell disease (SCD). For African-Americans in general, limited information is available in public databases. METHODS: We prioritized and examined the genotype and allele frequencies of 115 SNPs from 49 candidate pain genes in 199 adult African-Americans and pediatric patients of African origin with SCD. Analyses were performed and compared with available data from public databases. RESULTS: Genotype and allele frequencies of a number of SNPs were found to be different between our cohort and those from the databases and between adult and pediatric subjects. CONCLUSION: As pain therapy is inadequate in a significant percentage of patients with SCD, candidate pain genetic studies may aid in designing precision pain medicine. We provide prevalence data as a reference for prospective genetic studies in this population.
Authors: Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich Journal: Nat Genet Date: 2006-07-23 Impact factor: 38.330
Authors: Miriam O Ezenwa; Robert E Molokie; Zaijie Jim Wang; Yingwei Yao; Marie L Suarez; Veronica Angulo; Diana J Wilkie Journal: J Pain Symptom Manage Date: 2014-03-15 Impact factor: 3.612
Authors: Diana J Wilkie; Robert Molokie; Debra Boyd-Seal; Marie L Suarez; Young Ok Kim; Shiping Zong; Harriet Wittert; Zhongsheng Zhao; Yogen Saunthararajah; Zaijie J Wang Journal: J Natl Med Assoc Date: 2010-01 Impact factor: 1.798
Authors: A W Bergen; J Kokoszka; R Peterson; J C Long; M Virkkunen; M Linnoila; D Goldman Journal: Mol Psychiatry Date: 1997 Oct-Nov Impact factor: 15.992
Authors: Keesha L Powell-Roach; Yingwei Yao; Ellie H Jhun; Ying He; Marie L Suarez; Miriam O Ezenwa; Robert E Molokie; Zaijie Jim Wang; Diana J Wilkie Journal: PLoS One Date: 2019-11-11 Impact factor: 3.240